Isis Pharmaceuticals opens new R&D facility
Consolidates operations on a single site
US drugmaker Isis Pharmaceuticals has opened a new 176,000ft2 (14,864m2) corporate and research facility in Carlsbad, California, US.
The state-of-the-art complex consolidates the majority of Isis' operations into a single facility, which the firm says will foster its collaborative approach to drug discovery and development.
Isis and BioMed broke ground on the new building in June 2010. BioMed is an American real estate investment trust focused on providing properties to the life science industry.
‘Completed ahead of schedule and below budget, our new corporate home provides the ideal environment for us to continue to innovate and create the medicines of tomorrow,’ said Stanley Crooke, chairman and chief executive of Isis.
The building was designed to be science-centric with modern design features to foster interdisciplinary collaborations between the 300 people who work there, such as ample space to promote innovation, creative use of outdoor space to provide informal meeting areas for people to exchange ideas, bright laboratories with mobile lab bench cabinets, and landscaping designed to take advantage of Carlsbad's local water reclamation plant.
